Order Article Reprints

Zampiga V, Cangini I, Bandini E, Azzali I, Ravegnani M, Ravaioli A, Mancini S, Tebaldi M, Tedaldi G, Pirini F, et al. Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area. Cancers. 2023; 15(7):2132. https://doi.org/10.3390/cancers15072132

Zampiga, Valentina, Ilaria Cangini, Erika Bandini, Irene Azzali, Mila Ravegnani, Alessandra Ravaioli, Silvia Mancini, Michela Tebaldi, Gianluca Tedaldi, Francesca Pirini, and et al. 2023. "Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area" Cancers 15, no. 7: 2132. https://doi.org/10.3390/cancers15072132

Zampiga, V., Cangini, I., Bandini, E., Azzali, I., Ravegnani, M., Ravaioli, A., Mancini, S., Tebaldi, M., Tedaldi, G., Pirini, F., Veneroni, L., Frassineti, G. L., Falcini, F., Danesi, R., Calistri, D., & Arcangeli, V. (2023). Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area. Cancers, 15(7), 2132. https://doi.org/10.3390/cancers15072132